Beijing Tongrentang is a famous time-honored brand in the Chinese medicine industry. Founded in 1669 (the eighth year of Emperor Kangxi of Qing Dynasty), it has been dedicated to imperial medicine since 1723, and it has gone through eight emperors for 188 years. In the course of more than 3 years, Tongrentang people in past dynasties have always adhered to the old adage that "although the processing is complicated, they will not dare to save labor, and although the taste is expensive, they will not dare to reduce material resources", and they have established the self-discipline consciousness of "no one sees the combination, but god knows it", which has created the rigorous spirit of being careful and striving for perfection in the pharmaceutical process. Their products are well-known at home and abroad for their unique formula, excellent materials selection, exquisite technology and remarkable curative effect.
As the first well-known trademark in China, Tongrentang enjoys a unique brand advantage. Participated in the registration of Madrid Pact countries and Paris Convention countries, and was protected by international organizations. Registered in more than 5 countries and regions in the world, it is the first mainland trademark registered in Taiwan Province.
In p>1992, with the approval of Beijing Municipal Government, China Beijing Tongrentang Group Company was established. In 1997, Beijing Tongrentang Co., Ltd. was established exclusively, which was successfully listed in June of the same year. Since 1999, it has been selected as one of the "Top 5 Listed Companies with the Most Development Potential in China" for seven consecutive years, ranking first in 21 and 22. In 2, Beijing Tongrentang Co., Ltd. spun off 1 million yuan of excellent assets with high technology content and established Beijing Tongrentang Science and Technology Development Co., Ltd., becoming the first enterprise in China to raise funds twice with the same state-owned assets, and listed in Hong Kong, which was called "Tongrentang Model" by the industry. Tongrentang Technology Company's stock has always been one of the best performing stocks in Hong Kong Growth Enterprise Market.
In p>21, China Beijing Tongrentang Group Company was restructured into China Beijing Tongrentang (Group) Co., Ltd. In 22, Tongrentang Group was recommended by the National Federation of Industrial Economics and the Brand Strategy Promotion Committee as one of the 16 enterprises with the greatest impact on world famous brands. Publicity Department of the Communist Party of China was rated as an advanced unit in spiritual civilization construction. In 24, it was identified as one of the ten major state-owned enterprises by the State-owned Assets Supervision and Administration Commission of Publicity Department of the Communist Party of China and the State Council.
Since the Ninth Five-Year Plan, Tongrentang has maintained an average annual growth rate of about 2%. In 24, Tongrentang's total assets reached 6.3 billion yuan, with sales of 5 billion yuan and profits of 34 million yuan. At present, Tongrentang has a sales terminal network all over the world, with more than 4 branches, chain stores and shop-in-shop stores. Among them, 17 joint ventures and stores have been established in 12 countries and regions. In June, 24, Tongrentang Chinese Medicine Co., Ltd., an overseas production base, was established by purchasing 11,7 square meters of land in Hong Kong and investing 15 million Hong Kong dollars, which laid a good foundation for the internationalization of production, R&D and marketing. In 24, the joint-stock company production base, technology company production base and logistics distribution center built in Yizhuang Economic and Technological Development Zone with an investment of 6 million yuan have been completed and put into operation. This is the project with the largest investment scale and the highest level of production modernization in the history of Tongrentang. It has achieved "six first-class" from automatic control of preparation technology, production equipment and management system to energy control, environmental protection and construction quality, and is at the leading level in the same industry in China. At present, Tongrentang has formed a production preparation group consisting of five production bases in Daxing, Yizhuang, Liujiayao, Tongzhou and Changping, with 41 production lines, which can produce 26 dosage forms and more than 1, products.
In the main producing area of Chinese traditional medicine in China, Tongrentang has 12 green Chinese traditional medicine planting bases jointly built according to national GAP standards, with a total investment of 58 million yuan (including 29.58 million yuan invested by Tongrentang). Tongrentang will become a manufacturer and market supplier of medicinal materials on the basis of realizing the base supply of raw materials for its main products.
In p>21, in cooperation with the State Council Development Research Center, Tongrentang's development plan for the next ten years was formulated. Based on the principle of independent operation, each with its own emphasis, sharing resources and overall development, the "132" project supporting it has also made substantial progress. "1" refers to the top 1 companies including two listed companies; "32" refers to two hospitals (Tongrentang Research Institute and Tongrentang Chinese Medicine Hospital), two bases (Tongrentang Joint-stock Company and Tongrentang Technology Company's production bases in Yizhuang respectively) and two centers (Tongrentang Training Center and Tongrentang Information Center). At present, Tongrentang has basically formed the industrial layout of pharmaceutical industry, retail business and medical service.
Facing the new situation of world economic integration, Tongrentang's development strategy is to develop life and health industry with modern Chinese medicine as the core and become an internationally renowned Chinese medicine group. (
Reference: Baidu Encyclopedia)